The present disclosure relates generally to thienopyrimidine and thienopyridine compounds and methods of use thereof. In particular embodiments, the present disclosure provides compositions comprising thienopyrimidine and thienopyridine compounds of Formula 2:
and methods of use to inhibit the interaction of menin with MLL1, MLL2 and MLL-fusion oncoproteins.
本公开涉及
噻吩嘧啶和
噻吩吡啶化合物及其使用方法。在特定实施例中,本公开提供了由公式2的
噻吩嘧啶和
噻吩吡啶化合物组成的组合物,并提供了使用方法,以抑制Menin与MLL1、ML
L2和MLL融合癌蛋白的相互作用。